Viridian Therapeutics Announces First Subject Dosed in Phase 1/2 Clinical Trial of VRDN-001 for Thyroid Eye Disease (TED)

NEXT STORY
Global Mechanical Ventilators Market Outlook, 2026 – Getinge, Medtronic, Smiths Medical, Koninklijke Philips, and ResMed Dominate the Pandemic-Spurred Industry
PREV STORY
Global Infection Control Market 2021-2026: Surge in Growth for E-Beam Sterilization and Re-Introduction of Ethylene Oxide Sterilization
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Active Biotech AB Interim report January – June 2016

      Laquinimod The clinical trials CONCERTO, ARPEGGIO and LEGATO-HD are progressing according to plan The ...

author_avatar
NASDAQ Market News

CymaBay Reports First Quarter 2021 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Generex Biotechnology Announces Investor Conference Call Scheduled for July 25, 2019

author_avatar
NASDAQ Market News